ACC 2021 Discussion: The STRENGTH Study
- Видео
- О видео
- Скачать
- Поделиться
ACC 2021 Discussion: The STRENGTH Study
Host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Steven E Nissen (Cleveland Clinic, Cleveland, OH, US) to discuss the results from the secondary analysis of the STRENGTH Trial. The study assessed the long-term outcomes statin residual risk with epanova in high cardiovascular risk patients with hypertriglyceridemia. Recorded remotely from Cleveland and Hamilton, 2021. Editor: Mirjam Boros
322 | 3 год. назад | 7 - 0
Host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Steven E Nissen (Cleveland Clinic, Cleveland, OH, US) to discuss the results from the secondary analysis of the STRENGTH Trial. The study assessed the long-term outcomes statin residual risk with epanova in high cardiovascular risk patients with hypertriglyceridemia.
Recorded remotely from Cleveland and Hamilton, 2021.
Editor: Mirjam Boros
Чтобы скачать видео "ACC 2021 Discussion: The STRENGTH Study" передвинте ползунок вправо
- Комментарии
Комментарии ФБ